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Summary
Background: Although there are many reports on Ampulla Cardiomyopathy, its etio-
logic mechanisms are not well known.
Aim: Etiology of Ampulla Cardiomyopathy was investigated by myocardial scintigra-
phy with various nuclear tracers.
Subjects and methods: In nine patients with Ampulla Cardiomyopathy, myocardial
scintigraphy was performed at acute, subacute and chronic phases. Total defect
score (TDS) of tallium-201 (Tl) or technetrium-99m sestamibi (MIBI) myocardial
perfusion and iodine-123-beta-methyl-p-iodophenyl penta-decanoic acid (BMIPP)
scintigraphies was calculated. Cardio-mediastinal ratio (H/M) and washout rate (WR)
of early and delayed images of iodine-123-meta-iodobenzylguanidine (MIBG) scintig-
raphy were also calculated. The patients in whom TDS of myocardial perfusion
scintigraphy at acute phase was 0, were classiﬁed into group N (n = 5) and those
with TDS≥ 1 into group D (n = 4).
Results: TDS of BMIPP at acute, subacute and chronic phases was higher in D than
in N; 28.8± 10.3 vs. 7.2± 4.7 (p = 0.0039), 15.5± 2.1 vs. 1.0± 0.8 (p < 0.0001) and
2.7± 1.2 vs. 0 (p = 0.05), respectively. WR of MIBG at acute phase was also higher
in D (50.3± 5.7% vs. 36.6± 10.5%, p = 0.05). H/M (dH/M) on the delayed images and
WR at chronic phase were not different between the two groups. H/M (eH/M) on
the early images was lower in D. Blood noradrenaline (ng/ml) at acute phase was
.21± 0.55 vs. 0.45± 0.33, p < 0.05). Left ventricular ejectionhigher in D than in N (1
fraction (LVEF) was decreased in both at acute phase but it was lower in D than in
N (48.1± 3.7% vs. 69.9± 9.7%, p < 0.05) at subacute phase.
Conclusion: These ﬁndings suggest that the etiology of Ampulla Cardiomyopathy is
neurologically stunned myocardium induced by coronary microcirculatory disorder.
∗ Corresponding author at: Division of Cardiovascular Medicine, Department of Internal Medicine, Ohmori Hospital, Toho
niversity School of Medicine, 6-11-1 Ohmori-nishi, Ohta-ku, Tokyo 143-8541, Japan.
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Due to the signiﬁcant amount of time that was necessary for normalization of wall
motion in the D group, myocardial scintigraphy is believed to be also useful in assess-
ment of severity.
e of Cardiology. Published by Elsevier Ireland Ltd. All rights
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and 175± 24 (chronic phase) after hospitalization.
Electrocardiography© 2008 Japanese Colleg
reserved.
Introduction
Ampulla Cardiomyopathy is accompanied by chest
symptoms and ECG changes similar to acute
myocardial infarction. This disorder, however,
has no signiﬁcant coronary artery stenosis but
demonstrates a takotsubo shape with reduced con-
tractions centering in the apex and compensatory
basal hypercontraction [1—8]. Ampulla Cardiomy-
opathy is deﬁnitely not a rare disorder. It is revealed
in approximately 2% of patients undergoing emer-
gent cardiac catheterization in Japan. It is more
commonly seen in women 60 years or older, and the
association of some kind of emotional stress prior
to onset has been indicated. The basis for this diag-
nosis is said to be apical wall motion abnormalities,
which do not match up with coronary artery territo-
ries, and complete improvement over a few weeks
course of time. Since reported by Satoh et al. [1]
in 1990, similar cases have come to be reported
outside of Japan as well.
Various theories on the etiology of Ampulla Car-
diomyopathy have been reported including stunned
myocardium resulting from myocardial ischemia
due to multivessel epicardial coronary artery spasm
or microvascular spasm, catecholamine-induced
myocardial dysfunction, and myocarditis, but the
cause has yet to be elucidated. Myocardial scintig-
raphy is utilized as a noninvasive tool to grasp
the pathophysiology and evaluate the severity
of cardiac disease. In Japan three isotopes are
mainly used for imaging: myocardial perfusion
scintigraphy (tallium-201 (Tl) or technetrium-
99m sestamibi (MIBI)), iodine-123-beta-methyl-p-
iodophenyl penta-decanoic acid (BMIPP) scintig-
raphy for imaging of fatty acid metabolism
and iodine-123-meta-iodobenzylguanidine (MIBG)
scintigraphy for imaging of the sympathetic nervous
system. While we can ﬁnd reports in recent years of
studies conducted separately on Ampulla Cardiomy-
opathy, there are almost no reports of myocardial
scintigraphy using three isotopes during the same
interval and observed over a long period as well.
In this study, triple isotope imagings — myocar-
dial perfusion scintigraphy (with Tl or MIBI) and
BMIPP and MIBG scintigraphy — were conducted in
the acute, subacute, and chronic phases in nine
consecutive patients diagnosed with Ampulla Car-
E
o
1iomyopathy. The ﬁndings were used to consider
he pathophysiology of this disorder. We also stud-
ed the possibility of its usefulness in evaluating the
everity of Ampulla Cardiomyopathy.
ubjects and methods
ubjects
ine patients diagnosed as Ampulla Cardiomy-
pathy by left ventriculography and coronary
ngiography underwent MIBI, BMIPP and MIBG
cintigraphies at acute (mean; 6.2± 3.4 days), sub-
cute (mean; 46.6± 9.1 days), and chronic phases
mean; 171.4± 21.9 days) during January 2002
nd December 2004. The time lag between the
nset of symptoms and admission was 6.2± 5.5 h.
he diagnostic criteria of Ampulla Cardiomyopa-
hy were as follows: (1) elevated ST segment of
lectrocardiogram at the time of onset and large
egative T wave appearing over time, (2) no signif-
cant organic stenoses of the coronary arteries by
ngiography despite ST elevation, (3) by ventricu-
ography, reduced contraction of apical segment
hich does not correspond to the irrigating coro-
ary artery and augmented contraction of mid- to
asal segments showing octopus-trap-like conﬁgu-
ation, (4) mildly elevated plasma enzymes eluted
rom the myocardium, and (5) complete disappear-
nce of abnormal left ventricular contraction in
ater phase.
lood examinations
lood cell counts and biochemical examinations
ere performed on admission and they were
epeated in later phase. Brain natriuretic peptide
BNP), noradrenaline, adrenaline and dopamine
evels in the blood were also measured on days
.3± 0.6 (acute phase), 63± 9.6 (subacute phase),lectrocardiography was conducted in all patients
n days 2, 8.2± 2.4, 26± 6.4, 68± 8.8 and
42± 25.8 after hospitalization. The changes in ST
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ompulla Cardiomyopathy by scintigraphy
egments and T waves and QTc time were also
xamined repeatedly.
chocardiography
chocardiography was performed to examine left
entricular function on days 2.2± 1.4 and 8.8± 1.8
fter hospitalization and it was repeated every
eek until left ventricular wall motion became
ormal. Normalization in echocardiography was
eﬁned to be when complete improvement of local
all motion is revealed.
ardiac catheterization
eft ventriculography and coronary angiography
ith acetylcholine load were performed by inguinal
r radial approach using a 6 Fr catheter on admis-
ion and were repeated in ﬁve patients 7.2± 2.2
ays later. Acetylcholine was infused into the right
oronary artery, starting with 25g to provoke
pasm. When spasm was not induced, the dose
as increased up to 50g. Acetylcholine was also
nfused into the left coronary artery with 25g as
starting dose. When no spasms were induced, the
ose was increased up to 100g.
yocardial scintigraphy
yocardial scintigraphy using three nuclear types
f myocardial perfusion tracers (Tl or MIBI), BMIPP,
nd MIBG were conducted in all nine patients.
n six of them, Tl (111MBq) was administered
ntravenously at rest and radiograms were taken
min later for assessment of myocardial blood
ow. In three patients, MIBI (740MBq) was admin-
stered at rest and early and delayed images
ere taken after 45min and 4 h, respectively also
or assessment of myocardial blood ﬂow. MIBG
111MBq) was administered intravenously at rest
nd early and delayed images were taken after
0min and 4 h, respectively, for assessment of car-
iac sympathetic nerve activity. BMIPP (111MBq)
as infused intravenously at rest and early and
elayed images were taken after 20min and 4 h,
espectively for assessment of myocardial fatty acid
etabolism.
Time lag between scintigraphy and the onset
f symptoms was 6.8± 3.6 days at acute phase,
6± 9.6 days at subacute phase, and 171± 21.9
ays at chronic phase in Tl or MIBI myocardial per-
usion scintigraphy; 6.6± 3.3 days, 45± 9.7 days,
nd 171± 21.9 days, respectively in BMIPP myocar-
ial scintigraphy; 9.4± 2.5 days, 47± 8.1 days, and
75± 21.9 days, respectively in MIBG scintigraphy.
a
f
b
(123
mage analyses of myocardial scintigraphy
HA classiﬁcation [9] was used for myocardial per-
usion scintigraphy and BMIPP scintigraphy. Namely,
he shorter axial tomograms and vertical longer
xial tomograms of the myocardial SPECT images
ere divided into 17 segments, and the degree
f the defect was evaluated macroscopically at
ach segment using ﬁve steps (0: normal perfusion,
: mild hypoperfusion, 2: moderate hypoperfu-
ion, 3: severe hypoperfusion, 4: defect) (Fig. 1).
he total sum of degree of the defect was called
otal defect score (TDS). The presence of a mis-
atch [10,11] was deﬁned as the case in which
he TDS of the BMIPP scintigraphy was three points
r more higher than that of myocardial perfu-
ion scintigraphy. Five patients without defects
n Tl or MIBI myocardial perfusion scintigraphy at
he acute phase were assigned to group N and
our patients with defects were assigned to group
. TDS in BMIPP, and WR, eH/M and dH/M in
IBG were compared between the two groups. The
resence or absence of a mismatch was also inves-
igated.
tatistical analyses
umerical values are expressed as the mean
evel± standard deviation. To compare each
arameter between groups N and D, the unpaired
tudent’s t-test was used and a signiﬁcant
ifference was evaluated with p < 0.05.
esults
atient backgrounds
he patients were composed of seven females
nd two males, ages ranging from 55 to 90 years
ld with a mean of 73± 9.9 years old. Medical
istories were hypertension in three, hyperlipi-
emia in four, diabetes in one and epilepsy in
ne. Symptoms at the ﬁrst examination included
hest pain in ﬁve, epigastralgia in two, syncopy
n one and convulsion in one. Mental stresses
ere found in six before the onset (67%). The
ime required for improvement of left ventricu-
ar wall motion was 6.2± 2.8 days in group N and
5.3± 23.7 days in group D (Table 1). The mean
ge was 76± 9.4 in group N and 69± 10.4 years
ld in group D. Group N consisted of four females
nd one male and group D consisted of three
emales and one male. No differences in patient
ackground were found between the two groups
Table 2).
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Figure 1 Myocardial perfusion spectrae. The myocardial perfusion spectra were divided into 17 segments on the long
and short axial images and each segment was evaluated macroscopically with ﬁve steps.
Table 1 Backgrounds of nine patients with Ampulla Cardiomyopathy
Patient
number
Age (years)
and sex
Past history Symptoms Triggered event Normalization of
left ventricular
contraction and
mean days
Days
later
Mean
days
1 81F Myoma uterus Chest pain Human relations 7
6.2 ± 2.8
2 68F Hypertension,
epilepsy
Convulsion Hospitalization 10
3 74F Diabetes
mellitus
Epigastralgia None 4
4 68F Hyperlipidemia Syncope None 7
5 90M Hyperlipidemia Chest pain None 3
6 74M Lung cancer Chest pain Human relations 30
45.3 ± 23.77 79F Hyperlipidemia Chest pain Death of spouse 808 55F Hypertension Epigastralgia External injury 30
9 68F Hypertension, Chest pain Death of spouse 41
3
dhyperlipi-
demia
Serological and biochemical examinationsPeak CK level (normal: 49—159 IU/l) was
588± 853 IU/l in group N and 184± 53 IU/l
in group D, and the peak CK-MB (normal:
1—20 IU/l) was 28.6± 12.0 IU/l in group N and
m
i
w
<
Table 2 Backgrounds of patients in groups N and D
Group N (n = 5)
Age (years) 76.2± 9.4
Female gender 4 (80%)
Risk factors
Diabetes mellitus 1 (20%)
Hypertension 1 (20%)
Hyperlipidemia 2 (40%)
Rise in viral antibody titers 0
Data are presented as the mean value± S.D. or number (%) of pa
Fisher exact test was used.
* n.s. = not signiﬁcant.1.8± 14.2 IU/l in group D with no signiﬁcant
ifference between them. Troponin-I (nor-
al: <0.09 ng/ml) was 0.82 IU/l± 0.37 ng/ml
n group N and 2.54± 3.72 ng/ml in group D
ith no signiﬁcant difference. BNP (normal:
20.0 pg/ml) was 187.0± 90.4 pg/ml in group N
Group D (n = 4) p value
69.4± 10.4 n.s.*
3 (75%) n.s.
0 n.s.
2 (40%) n.s.
2 (40%) n.s.
0 n.s.
tients or control subjects. The unpaired Student’s t-test or
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Table 3 Blood cell count and biochemical examinations at admission
Patient number CK (IU/l) CK-MB (IU/l) Troponin-I (ng/ml) NE (ng/ml) BNP (pg/ml) Peak cardiac enzymes
CK (IU/l) CK-MB (IU/l)
1 348 34 0.70 0.21 80 421 37
2 1221 21 0.34 0.29 112 2096 21
3 169 45 1.12 0.67 194 203 45
4 76 17 1.27 0.69 263 152 24
5 67 16 0.69 0.39 286 67 16
6 89 15 0.17 1.60 39 238 28
7 92 14 0.81 1.20 17 112 14
8 200 47 8.09 1.60 2260 200 47
9 187 38 1.07 0.44 486 187 38
CK = creatinine kinase, CK-MB =MB isoenzyme of creatinine kinase,
IU = international units.
and 700.5± 1061.9 pg/ml in group D with no signif-
icant difference. No differences were found in all
data between the two groups at the subacute and
chronic phases (Table 3). No signiﬁcant differences
in the blood adrenaline and dopamine levels were
found during the entire periods, whereas blood
noradrenaline (normal: 0.06—0.50 ng/dl) in group
D at the acute phase was signiﬁcantly (p < 0.05)
higher than that in group N (1.21± 0.55 ng/dl
vs. 0.45± 0.22 ng/dl). However, noradrenaline
was not different between the two groups at
subacute and chronic phases (0.64± 0.11 ng/dl
vs. 0.71± 0.34 ng/dl and 0.69± 0.14 ng/dl vs.
0.72± 0.26 ng/dl, respectively) (Fig. 2). The viral
antibody titer measured with a pair sera was
negative in all patients (data are not shown).
Electrocardiographic ﬁndings
Elevated ST segment electrocardiogram taken at
the ﬁrst visit was found in six and an abnormal
Q wave was found in two of these nine patients.
A large negative T wave of electrocardiogram was
found on mean day 3± 4 (1—9 days) after symptom
Figure 2 Blood noradrenaline levels in groups N and D.
Data are presented as the mean value± S.D. Acute: acute
phase, subacute: subacute phase, chronic: chronic phase.
o
d
t
(
l
m
9
t
a
d
o
5
l
w
n
7
g
E
E
o
r
a
i
e
N
d
b
t
g
6
m
l
6
C
C
sNE=plasma norepinephrine, BNP = brain natriuretic peptide,
nset in all patients. QTc time on the ﬁrst disease
ay (normal level < 480ms) was 460± 45ms and the
ime on the second disease day was 520± 71ms
447—622ms), showing markedly prolonged QTc
evels on both days. Electrocardiographic abnor-
alities such as ST-T change were normalized
1± 40 days after symptom onset. QTc time on
he ﬁrst disease day was 454± 34ms in group N
nd 467± 64ms in group D, showing no signiﬁcant
ifference between them. QTc time on the sec-
nd disease day was 522± 72ms in group N and
15± 84ms in group D. Although QTc was thus pro-
onged in both groups, no signiﬁcant differences
ere found between them. The time required for
ormalization of electrocardiographic changes was
4± 49.9 days in group N and 107± 20.1 days in
roup D, showing no signiﬁcant difference.
chocardiographic ﬁndings
chocardiography of the left ventricle conducted
n day 2.2± 1.4 after symptom onset revealed
educed contraction of the apical segment and
ugmented contraction of the basal segments show-
ng octopus-trap-like conﬁguration. Left ventricular
jection fraction (LVEF) was 58.2± 18.8% in group
and 53.2± 3.6% in group D, showing no signiﬁcant
ifference between them. LVEF was improved in
oth groups 8.8± 1.8 days after the onset of symp-
oms, however, the magnitude of improvement in
roup D was smaller than group N (48.1± 3.7% vs.
9.9± 9.7%, p < 0.05). The time required for nor-
alization of the left ventricular contraction was
onger in group D than group N (45± 2.3 days vs.
.2± 2.8 days, p < 0.05).ardiac catheterization
oronary angiography revealed no signiﬁcant
tenotic lesions in the coronary arteries, nor slow
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Table 4 The total defect scores in MPS and 123I-BMIPP
Patient number Acute Subacute Chronic
MPS 123I-BMIPP MPS 123I-BMIPP MPS 123I-BMIPP
Group N
1 0 4 0 2 0 0
2 0 4 0 1 0 0
3 0 6 0 1 — —
4 0 15 0 0 — —
5 0 7 0 1 — —
Group D
6 9 19 0 14 0 2
7 11 21 — — 0 2
8 20 35 0 17 0 4
9 27 40 — — — —
aphies at acute phase in groups N and D.Figure 3 Typical myocardial scintigr
coronary blood ﬂow in any patients. Spasm provo-
cation test by intracoronary acetylcholine was
performed on day 7.2± 2.2 after hospitalization
and it was provoked in the large epicardial coro-
nary artery in two of ﬁve patients. In one patient,
diffuse coronary spasm was induced in the left
anterior descending artery (middle to distal seg-
ments) which was accompanied by ST elevation.
Similarly, spasm of the right coronary artery (distal
segment) accompanied by ST elevation was pro-
voked in another patient.
Myocardial scintigraphy
The myocardial perfusion scintigraphy at the acute
phase revealed no defect of the TDS in group N
while defect was observed in all four of group D.
TDS of these four patients was 9, 11, 20, and 27.
However, these defects disappeared at subacute
and chronic phases (Table 4). Typical myocardial
Figure 4 The total defect scores in 123I-BMIPP in groups
N and D. The scores at the acute 123I-BMIPP; iodine-123-
beta-methyl-p-iodophenyl penta-decanoic acid.
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Table 5 WR and H/Ms with 123I-MIBG
Group WR
(acute) (%)
H/M ratio
(acute)
WR
(subacute) (%)
H/M ratio
(subacute)
WR
(chronic) (%)
H/M ratio
(chronic)
Group N
Early 36.6 ± 10.5 2.05 ± 0.19 36.8 ± 9.9 2.07 ± 0.25 35.7 ± 6.5 2.39 ± 0.22
Delayed 1.93 ± 0.15 2.02 ± 0.27 2.31 ± 0.28
Group D
Early 50.3 ± 5.7 1.82 ± 0.30 39.7 ± 7.0 1.91 ± 0.17 37.0 ± 9.8 1.99 ± 0.13
Delayed 1.62 ± 0.29 1.78 ± 0.32 1.94 ± 0.32
e phase; subacute: subacute phase; chronic: chronic phase.
s
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eWR: washout rate, H/M: heart/mediastinum ratio; acute: acut
cintigraphies at acute phase are shown in Fig. 3.
n BMIPP scintigraphy, TDS at acute phase was
.2± 4.6 in group N and 28.8± 10.3 in group D,
howing a signiﬁcant difference between them
p = 0.0039). TDS at subacute phase was 1.6± 1.5
n group N and 15.5± 2.1 in group D, showing a sig-
iﬁcantly higher level in group D (p < 0.0001). TDS
t chronic phase was 0 in group N and 2.7± 1.2 in
roup D, showing a higher level in group D (p = 0.05)
Fig. 4). Mismatch was found between the myocar-
ial perfusion scintigraphy and BMIPP scintigraphy
t acute phase in all patients. In the results of
IBG scintigraphy (Table 5), the WRs at the acute
hase were 36.6± 10.5% in group N and 50.3± 5.7%
n group D, showing a higher level in group D
p = 0.05). However, no signiﬁcant differences were
ound at subacute and chronic phases between the
wo groups (Fig. 5).
eH/M at acute and subacute phases in groups
and D was 2.05± 0.19 vs. 1.82± 0.30 and
.07± 0.25 vs. 1.91± 0.17, showing no signiﬁcant
ifference between them. At chronic phase, how-
i
l
1
s
Table 6 H/Ms and LVEF and MIBG between groups N and D
Group N (n = 5)
MIBG early H/M
Acute 2.05 ± 0.19
Subacute 2.07 ± 0.25
Chronic 2.39 ± 0.22
MIBG delay H/M
Acute 1.93 ± 0.15
Subacute 2.02 ± 0.27
Chronic 2.31 ± 0.28
Ejection fraction (%)
Acute 58.2 ± 18.8
Subacute 69.9 ± 9.7
Chronic 68.4 ± 4.2
Data are presented as the mean value± S.D. n.s. = not signiﬁcant.igure 5 The washout rates of 123I-MIBG in groups N and
. 123I-MIBG: iodine-123-meta-iodobenzylguanidine.
ver, it was 2.39± 0.22 in group N and 1.99± 0.13
n group D (p < 0.05), exhibiting a signiﬁcantly lower
evel in group D. dH/M level at acute phase was
.93± 0.15 in group N and 1.62± 0.29 in group D,
howing a lower tendency in group D. However, no
Group D (n = 4) p value
1.82 ± 0.30 n.s.
1.91 ± 0.17 n.s.
1.99 ± 0.13 p < 0.05
1.62 ± 0.29 p = 0.07
1.78 ± 0.32 n.s.
1.94 ± 0.32 n.s.
53.2 ± 3.6 n.s
48.1 ± 3.7 p < 0.05
76.0 ± 3.3 n.s.
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signiﬁcant difference was found in it between them
at subacute and chronic phases (Table 6).
Discussion
In this present study, we attempted to elucidate
the etiology of Ampulla Cardiomyopathy through
the different myocardial scintigraphies taken in
the acute, subacute, and chronic phases. The fol-
lowing summarizes the results of cardiac nuclear
medicine studies on nine patients with Ampulla
Cardiomyopathy. (1) Mismatch between myocar-
dial perfusion scintigraphy and BMIPP scintigraphy
conducted in the acute period was seen in all sub-
jects. MIGB scintigraphy in the acute period also
revealed defects in the same site in all patients.
Normalization of uptake was seen in the order of
myocardial perfusion scintigraphy, BMIPP and MIBG.
(2) Between the N group, which was found to be
normal in myocardial perfusion scintigraphy in the
acute phase, and the D group, which revealed
defects, signiﬁcant differences were revealed in
the degree of BMIPP and MIBG defects, plasma nora-
drenaline levels, and period until resolution of left
wall motion abnormalities.
In this study, a mismatch was revealed between
myocardial perfusion scintigraphy and BMIPP in
all nine patients with Ampulla Cardiomyopathy.
According to Tamaki et al. [10] cases of acute
myocardial infarction successfully achieving reper-
fusion revealed a strong mismatch with greater
BMIPP defects compared to myocardial perfusion
tracer defects. They report that this reﬂects the
salvage area [12]. It is also said that when a mis-
match between T1 and BMIPP is revealed in patients
with chronic ischemic heart disease, this demon-
strates the presence of myocardial ischemia [13].
Hashimoto et al. [14] report that the presence
of mismatch demonstrates myocardial stunning or
hibernation. Additionally, according to Bax et al.
[15] among patients with stunned myocardium,
approximately 61% improve within 3 months. It is
said that in patients with MIBG mismatch, defects
are generally revealed at the same site as that of
BMIPP.
In patients with stunned myocardium, myocar-
dial scintigraphy also improves in line with recovery
of wall motion, and this recovery is said to occur
in the order of myocardial perfusion scintigraphy,
BMIPP, and MIBG. This is extremely similar to the
changes we were able to observe in the different
myocardial scintigraphies of this present study of
Ampulla Cardiomyopathy. The only dissimilar point
was that the defect site in Ampulla Cardiomy-
opathy did not match any clear coronary artery
t
W
m
iY. Uchida et al.
erritory. Meanwhile, it has also been pointed out
hat noradrenaline is associated with the etiol-
gy of Ampulla Cardiomyopathy. In neurological
tunned myocardium [16] associated with cerebral
ascular disorders or pheochromocytoma-induced
atecholamine cardiomyopathy, along with the
ncrease of endogenous catecholamines, mediation
y alpha 2 receptors induces coronary microvas-
ular spasm. It is believed that because of this,
latelet aggregation is accelerated, cell membrane
ermeation increases, and due to this, calcium
oad occurs in the myocardial cells followed by
ell death, resulting in myocardial dysfunction [17].
imons and Downing [18] report that in animal
ests an increase in coronary vessel resistance and
iminished ﬂow was manifested through contin-
ous administration of noradrenaline. Regarding
hy reduction in wall motion occurs mainly in
he apex, when considering reports noting a den-
ity of stellate ganglia of the cardiac sympathetic
erves centering in the apex, and that nora-
renaline is released from the stellate ganglion,
here is the possibility that noradrenaline is associ-
ted with this mechanism. Based on MIBG ﬁndings,
kashi et al. [8] are looking at the neurological
tunned myocardium as the etiology of this dis-
rder. But because MIBG defects are also noted
t times of functional disorders in the sympa-
hetic nervous system [19] or when denervation of
he sympathetic nerves in the myocardium occurs
ue to severe ischemia such as acute myocardial
nfarction, it would be difﬁcult to pin the cause
f Ampulla Cardiomyopathy on the neurological
tunned myocardium based on MIBG ﬁndings alone.
ur observations in this present study, though,
lso showed levels of plasma noradrenaline ris-
ng in association with the increasing severity of
ases, namely cases revealing slow recovery of wall
otion and even defects in the perfusion scintigram
s well. From these observations, we believe it
ighly possible that the mechanism for the onset of
eurological Ampulla Cardiomyopathy is neurologi-
al stunned myocardium, in which an acceleration
f cardiac sympathetic nerve activity causes the
elease of noradrenaline that induces coronary
icrovascular ischemia, which in turn results in
educed wall motion due to stunned myocardium.
While the prognosis of Ampulla Cardiomyopathy
s generally viewed to be good, cases complicated
y heart failure and arrhythmia have been noted
t times, making evaluation of severity impor-
ant. Myocardial perfusion scintigraphy is used
o assess myocardial perfusion and viability [20].
hen exposed to severe ischemia such as acute
yocardial infarction or unstable angina, defects
n myocardial perfusion scintigraphy are revealed,
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Rmpulla Cardiomyopathy by scintigraphy
atching the reduction of wall motion and the site
f ischemia [21,22]. On the other hand, when the
egree of ischemia is moderate, we often experi-
nce cases that do not show defects in myocardial
erfusion scintigraphy. Watanabe et al. [23] have
eported that in stunned myocardium induced by
requent onsets of vasospastic angina (VSA), tran-
ient reduction of wall motion and BMIPP defects
ere revealed, but the T1 myocardial scintigram
as normal. Because of this, in this present study
e classiﬁed the patients into the group with nor-
al perfusion scintigraphy in the acute phase (N
roup) and the group revealing defects (D group),
nd examined the two groups for differences. Both
roups showed BMIPP defects in the acute phase,
ut the D group had signiﬁcantly higher TDS. While
tendency for improvement in the subacute and
hronic phases was seen in both groups, the TDS
f the D group was signiﬁcantly higher than the
group even in the subacute phase. It has been
eported that in ischemic heart disease, patients
ith strong BMIPP defects have delayed improve-
ent of wall motion [14,24]. In addition, in a canine
tudy by Hosokawa et al. [25], BMIPP defects did
ot appear in moderate ischemia as that caused
y blockage of coronary ﬂow for 10min, but clear
MIPP defects appeared in severe ischemic condi-
ions similar to 30min of occlusion. Regarding MIBG,
oth groups revealed eH/M and dH/M decrease and
R increase in the acute phase, but compared to
he N group, the D group showed a tendency for
ower dH/M and a tendency for higher WR. In the
ubacute phase, both groups showed a tendency
or gradual improvement, with no signiﬁcant dif-
erence revealed.
In the chronic phase, eH/M and dH/M were
ormalized in the N group, but was low in the
group, with eH/M signiﬁcantly lower in the D
roup. Due to the fact that WR remained high in
oth D and N groups without achieving a normal
ate, it became clear that damage to the sympa-
hetic nervous system and its increased activity are
rolonged in Ampulla Cardiomyopathy. This ten-
ency was distinctly seen in the D group, which
ad defects in myocardial perfusion tracers in the
cute phase. In cardiac ultrasound, the N and D
roups revealed no signiﬁcant difference in car-
iac functions at the time of hospital admission.
ut while wall motion of the N group normal-
zed within 1 week, wall motion in the D group
howed no improvement. It is believed that the
group manifested more severe ischemia com-ared to the N group due the large degree of
efects in both myocardial perfusion tracers and
MIPP, and the delay in their improvement. From
hese ﬁndings, it was believed that the longer129
uration of spasms in the D group compared to
he N group may have led to a higher degree of
yocardial ischemia. In addition, from the fact that
lasma noradrenaline levels were higher in the D
roup, it was suggested that similar to neurologi-
al stunned myocardium associated with cerebral
ascular disorders, myocardial ischemia could have
een induced by coronary microvascular spasm due
o plasma noradrenaline. From our observations in
his study, myocardial scintigraphy was believed to
e also useful in assessing the severity of Ampulla
ardiomyopathy.
tudy limitations
ifferent to myocardial infarction caused by
rganic coronary disease, Ampulla Cardiomyopathy
s rare disease. Therefore, only nine patients could
e investigated in this study. Therefore, studies
sing larger number of patients should be carried
ut to clarify the etiology of this disease.
In this study, the reasons are still unknown as
o why the reduction of the wall movement occurs
ainly at the apex. Mori et al. [26] reported that
he density of astrocytic ganglions of the cardiac
ympathetic nerve is speciﬁcally high at the apex.
herefore, in addition to the difference in coro-
ary anatomy between apical and basal areas, it
hould be clariﬁed whether or not noradrenaline is
ecreted from the astrocytic ganglions and is accu-
ulated in the apical area. In this study, it was not
lariﬁed whether or not noradrenaline increased
rimarily due to stresses or secondary to ischemia
f the microvasculature circulation through reﬂex
xcitation of sympathetic efferent nerves due to
xcitation of sympathetic afferent nerves.
onclusion
rom the ﬁndings of triple isotope myocardial
cintigraphy and the changes in plasma nora-
renaline, it was inferred that the etiology of
mpulla Cardiomyopathy is neurological stunned
yocardium on the coronary microvascular level.
yocardial scintigraphy was also extremely useful
n assessing the severity of Ampulla Cardiomyopa-
hy.
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